OrbiMed Capital GP III LLC insider trades: ViewRay (VRAY) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where OrbiMed Capital GP III LLC reports to the SEC
and 6 more companies
Open-market buys and sales
55 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 20, 2018 | VRAY | ↓ Sell | 521,607 | $9.95 | $5.2M | Indirect | Aug 20, 2018 (0d) |
| Aug 15, 2018 | VRAY | ↓ Sell | 185,948 | $9.95 | $1.9M | Indirect | Aug 15, 2018 (0d) |
| Aug 10, 2018 | VRAY | ↓ Sell | 1,368,796 | $9.97 | $13.6M | Indirect | Aug 10, 2018 (0d) |
| Aug 7, 2018 | VRAY | ↓ Sell | 169,920 | $11.20 | $1.9M | Indirect | Aug 7, 2018 (0d) |
| Apr 30, 2018 | PIRS | ↓ Sell | 1,000,000 | $6.35 | $6.3M | Indirect | May 2, 2018 (2d) |
| Mar 6, 2018 | GKOS | ↓ Sell | 836,500 | $32.02 | $26.8M | Indirect | Mar 6, 2018 (0d) |
| Feb 13, 2018 | PIRS | ↓ Sell | 7,897 | $8.98 | $71K | Indirect | Feb 15, 2018 (2d) |
| Jan 3, 2018 | PIRS | ↓ Sell | 1,709,620 | $7.35 | $12.6M | Indirect | Jan 4, 2018 (1d) |
| Dec 18, 2017 | PIRS | ↓ Sell | 147,635 | $5.70 | $842K | Indirect | Dec 20, 2017 (2d) |
| Oct 3, 2017 | ROKA | ↓ Sell | 201,617 | $0.68 | $137K | Indirect | Oct 5, 2017 (2d) |
| Sep 29, 2017 | ROKA | ↓ Sell | 474,676 | $0.72 | $344K | Indirect | Oct 2, 2017 (3d) |
| Sep 27, 2017 | ROKA | ↓ Sell | 127,601 | $0.98 | $126K | Indirect | Sep 28, 2017 (1d) |
| Sep 5, 2017 | GKOS | ↓ Sell | 580,200 | $38.73 | $22.5M | Indirect | Sep 5, 2017 (0d) |
| Aug 24, 2017 | ROKA | ↓ Sell | 14,300 | $1.50 | $21K | Indirect | Aug 25, 2017 (1d) |
| Aug 22, 2017 | ROKA | ↓ Sell | 75,276 | $1.52 | $114K | Indirect | Aug 22, 2017 (0d) |
| Aug 17, 2017 | GKOS | ↓ Sell | 325,000 | $37.93 | $12.3M | Indirect | Aug 17, 2017 (0d) |
| Mar 14, 2017 | GKOS | ↓ Sell | 382,538 | $45.33 | $17.3M | Indirect | Mar 14, 2017 (0d) |
| Mar 3, 2017 | GKOS | ↓ Sell | 55,772 | $47.05 | $2.6M | Indirect | Mar 7, 2017 (4d) |
| Jan 18, 2017 | VRAY | ↑ Buy | 330,577 | $3.00 | $992K | Indirect | Jan 20, 2017 (2d) |
| Aug 22, 2016 | VRAY | ↑ Buy | 1,138,074 | $2.95 | $3.4M | Indirect | Aug 24, 2016 (2d) |
| Aug 12, 2016 | GKOS | ↓ Sell | 292,938 | $33.69 | $9.9M | Indirect | Aug 12, 2016 (0d) |
| Aug 3, 2016 | GKOS | ↓ Sell | 425,000 | $30.59 | $13.0M | Indirect | Aug 5, 2016 (2d) |
| Jun 27, 2016 | SELB | ↑ Buy | 550,000 | $14.00 | $7.7M | Indirect | Jun 29, 2016 (2d) |
| Jun 27, 2016 | SELB | ↑ Buy | 550,000 | $14.00 | $7.7M | Indirect | Jun 29, 2016 (2d) |
| Jun 16, 2016 | RBM | ↑ Buy | 892,858 | $0.56 | $500K | Indirect | Jun 20, 2016 (4d) |
| Oct 12, 2015 | SIEN | ↓ Sell | 287,891 | $5.98 | $1.7M | Indirect | Oct 13, 2015 (1d) |
| Oct 9, 2015 | SIEN | ↓ Sell | 666,609 | $7.18 | $4.8M | Indirect | Oct 9, 2015 (0d) |
| Oct 6, 2015 | SIEN | ↓ Sell | 193,000 | $8.71 | $1.7M | Indirect | Oct 6, 2015 (0d) |
| Oct 1, 2015 | SIEN | ↓ Sell | 101,898 | $10.24 | $1.0M | Indirect | Oct 1, 2015 (0d) |
| Sep 28, 2015 | SIEN | ↓ Sell | 150,908 | $10.58 | $1.6M | Indirect | Sep 28, 2015 (0d) |
| Jul 6, 2015 | PIRS | ↑ Buy | 500,000 | $2.75 | $1.4M | Indirect | Jul 8, 2015 (2d) |
| Jul 22, 2014 | ROKA | ↑ Buy | 383,333 | $12.00 | $4.6M | Indirect | Jul 24, 2014 (2d) |
| Nov 7, 2013 | RBM | ↑ Buy | 816,325 | $2.45 | $2.0M | Indirect | Nov 12, 2013 (5d) |
| May 23, 2013 | AMBI | ↑ Buy | 33,800 | $6.91 | $234K | Indirect | May 24, 2013 (1d) |
| May 21, 2013 | AMBI | ↑ Buy | 680,471 | $7.97 | $5.4M | Indirect | May 22, 2013 (1d) |
| Sep 4, 2012 | AMRN | ↓ Sell | 233,700 | $14.43 | $3.4M | Indirect | Sep 5, 2012 (1d) |
| Jul 27, 2012 | AMRN | ↓ Sell | 366,300 | $14.61 | $5.4M | Indirect | Jul 30, 2012 (3d) |
| Jul 13, 2012 | GNOM | ↓ Sell | 1,207,936 | $2.74 | $3.3M | Indirect | Jul 13, 2012 (0d) |
| Jun 19, 2012 | AMRN | ↓ Sell | 617,100 | $12.91 | $8.0M | Indirect | Jun 19, 2012 (0d) |
| Mar 12, 2012 | PCRX | ↓ Sell | 100,100 | $11.11 | $1.1M | Indirect | Mar 13, 2012 (1d) |
| Feb 29, 2012 | PCRX | ↓ Sell | 42,100 | $11.05 | $465K | Indirect | Feb 29, 2012 (0d) |
| Feb 3, 2012 | PCRX | ↓ Sell | 143,300 | $10.91 | $1.6M | Indirect | Feb 3, 2012 (0d) |
| Oct 31, 2011 | PCRX | ↓ Sell | 97,441 | $10.53 | $1.0M | Indirect | Nov 2, 2011 (2d) |
| May 2, 2011 | AMRN | ↓ Sell | 132,900 | $16.08 | $2.1M | Indirect | May 3, 2011 (1d) |
| Apr 26, 2011 | ATHX | ↓ Sell | 168,500 | $2.91 | $491K | Indirect | Apr 29, 2011 (3d) |
| Apr 21, 2011 | AMRN | ↓ Sell | 750,000 | $16.67 | $12.5M | Indirect | Apr 25, 2011 (4d) |
| Apr 20, 2011 | AMRN | ↓ Sell | 3,800,000 | $15.31 | $58.2M | Indirect | Apr 20, 2011 (0d) |
| Apr 14, 2011 | ATHX | ↓ Sell | 20,700 | $2.91 | $60K | See Foonotes | Apr 29, 2011 (15d) |
| Apr 14, 2011 | ATHX | ↓ Sell | 200 | $2.91 | $582 | See Foonote | Apr 29, 2011 (15d) |
| Mar 28, 2011 | AMRN | ↓ Sell | 173,000 | $7.41 | $1.3M | Indirect | Mar 28, 2011 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About OrbiMed Capital GP III LLC's insider trades
OrbiMed Capital GP III LLC is a 10% owner of ViewRay (VRAY). Since Feb 8, 2011, it has reported 11 open-market purchases worth $37.6M and 44 sales worth $261.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include conversions (6 filings), other transactions (5 filings), option exercises (4 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VRAY insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.